News Daily News Dabigatran Cost-Effective Only for A-Fib Patients at High Stroke Risk L.A. McKeown June 03, 2011
News Conference News SCAI Launches Nationwide Cath Lab Quality Improvement Effort Jason Kahn May 09, 2011
CME Balancing Ischemic and Bleeding Risk with Antiplatelet Therapy: Personalizing Treatment to Optimize Outcomes